Nearly 100 people reached out to STAT following a column on the difficulty of pu...
A new HHS rule takes a far too narrow approach to health care data interoperabil...
Licensing requirements make it hard to become a therapist — harder, many advocat...
Negotiations over policies to extend increases to doctors' Medicare pay and incr...
Testosterone didn't lower fracture risk in a surprising new study. Researchers h...
The Biden administration wants to force insurance companies to give specific rea...
The decision invalidates all claims of patent infringement, which has been centr...
AI in telemedicine for behavioural health can revolutionise patient access to tr...
Speaking at Davos, WHO chief Dr. Ghebreyesus said learning lessons from the Covi...
In a report, findings suggested that cancer patients in the Netherlands will fac...
The Switzerland based company plans to use the Series B money to fund clinical t...
KBI Biopharma and Argonaut have entered into a strategic partnership to provide ...
The US FDA has approved Vertex's CASGEVY, a gene-edited cell therapy, to treat t...
The EC has granted orphan drug designation (ODD) for Precigen's PRGN-2012 aimed ...
The British health insurance and coverage provider is well-placed to invest in n...
Coya plans to file investigational new drug applications for COYA 302 in amyotro...
